JPS6337799B2 - - Google Patents

Info

Publication number
JPS6337799B2
JPS6337799B2 JP55057162A JP5716280A JPS6337799B2 JP S6337799 B2 JPS6337799 B2 JP S6337799B2 JP 55057162 A JP55057162 A JP 55057162A JP 5716280 A JP5716280 A JP 5716280A JP S6337799 B2 JPS6337799 B2 JP S6337799B2
Authority
JP
Japan
Prior art keywords
formula
compound
diazo
isomer
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP55057162A
Other languages
English (en)
Japanese (ja)
Other versions
JPS55147300A (en
Inventor
Aaru Buroomu Toomasu
Daburyu Metokarufu Burian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richardson Vicks Inc
Original Assignee
Richardson Vicks Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Vicks Inc filed Critical Richardson Vicks Inc
Publication of JPS55147300A publication Critical patent/JPS55147300A/ja
Publication of JPS6337799B2 publication Critical patent/JPS6337799B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
JP5716280A 1979-05-02 1980-05-01 Novel steroid* 5 alphaareductase inhibitor Granted JPS55147300A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3535779A 1979-05-02 1979-05-02

Publications (2)

Publication Number Publication Date
JPS55147300A JPS55147300A (en) 1980-11-17
JPS6337799B2 true JPS6337799B2 (enrdf_load_stackoverflow) 1988-07-27

Family

ID=21882177

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5716280A Granted JPS55147300A (en) 1979-05-02 1980-05-01 Novel steroid* 5 alphaareductase inhibitor

Country Status (3)

Country Link
JP (1) JPS55147300A (enrdf_load_stackoverflow)
BE (1) BE883091A (enrdf_load_stackoverflow)
ZA (1) ZA802452B (enrdf_load_stackoverflow)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ225100A (en) * 1987-06-29 1991-09-25 Merck & Co Inc Reaction of steroids (including 4-azasteroids) with a silylating agent in the presence of a quinone to introduce a delta' double bond and silylated intermediates

Also Published As

Publication number Publication date
ZA802452B (en) 1981-04-29
JPS55147300A (en) 1980-11-17
BE883091A (fr) 1980-09-01

Similar Documents

Publication Publication Date Title
US4317817A (en) Novel steroid 5α-reductase inhibitors
RU2141967C1 (ru) ИНГИБИТОРЫ ТЕСТОСТЕРОН 5α-РЕДУКТАЗЫ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ И СПОСОБ ИНГИБИРОВАНИЯ АКТИВНОСТИ ТЕСТОСТЕРОН 5α-РЕДУКТАЗЫ
US4396615A (en) Method of treating androgen-related disorders
IL91968A (en) Aromatic steroid 5-alpha-reductase inhibitors and pharmaceutical compositions containing them
US4088760A (en) Testosterone 5α-reductase inhibitors
JPH0227975B2 (enrdf_load_stackoverflow)
RU2141966C1 (ru) Антиандрогенные соединения, предшественник антиандрогенного соединения, фармацевтические композиции
NO168892B (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 17beta-(cyclopropyloxy)androst-5-en-3beta-ol-derivater
JP2750621B2 (ja) ３β，１７β―ヒドロキシ―置換ステロイド及び関連するステロイド化合物類
JPS6337799B2 (enrdf_load_stackoverflow)
EP0155934B1 (en) Pharmaceutical compositions for treating androgen-related disorders in humans
DE3017015C2 (enrdf_load_stackoverflow)
EP0414530B1 (en) 3-Nitro-substituted steroid derivatives
JP5061109B2 (ja) 抗性腺刺激剤としての９，１１−コルテキソロンのＣ３−Ｃ１０１７α−エステル類
HU213608B (en) Process for producing 2 beta,19-(methylene-amino)-androst-4-ene-3,17-dione as aromatase inhibitor and pharmaceutical composition containing it
JP4694068B2 (ja) テストステロン−５α−レダクターゼ阻害剤
HRP20030256A2 (en) 4-halogenated 17-methylene steroids, method for the production thereof and pharmaceutical compositions containing these compounds
CH645389A5 (fr) Derive halogene de la serie du 16alpha-methyl pregnane, sa preparation et composition le renfermant.
AU718358B2 (en) Inhibitors of testosterone 5-alpha reductase activity
Bhatnagar et al. Experimental comparative studies with the new aromatase inhibitors CGS 16949 and CGS 20267
Johnson Endocrine aspects and hormonal treatment of hepatocellular carcinoma: An overview
NZ230957A (en) Aromatic steroid 5-alpha-reductase inhibitors and pharmaceutical compositions
NZ280175A (en) Inhibiting testosterone 5alpha-reductase activity using an A ring modified 4-aza-3-oxo-cyclopentanoperhydrophenarthrene substituted in position-17beta by amino or acylamino
IT8322386A1 (it) Metodo di trattamento dei disturbi androginici
JPH0524126B2 (enrdf_load_stackoverflow)